Nutex Health (NASDAQ:NUTX) Shares Gap Up on Earnings Beat

Nutex Health Inc. (NASDAQ:NUTX) gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $99.20, but opened at $120.81. Nutex Health shares last traded at $118.70, with a volume of 97,107 shares changing hands.

The company reported ($2.95) earnings per share (EPS) for the quarter, topping the consensus estimate of ($5.43) by $2.48. The firm had revenue of $243.99 million for the quarter, compared to the consensus estimate of $221.93 million. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%.

Analyst Ratings Changes

Several research analysts recently commented on NUTX shares. Wall Street Zen cut Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, October 18th. Maxim Group set a $205.00 price objective on Nutex Health and gave the stock a “buy” rating in a report on Tuesday, August 26th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Nutex Health in a research note on Wednesday, October 8th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. Austin Asset Management Co Inc acquired a new position in shares of Nutex Health in the 2nd quarter valued at about $315,000. Goldman Sachs Group Inc. raised its stake in Nutex Health by 17.9% during the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after acquiring an additional 2,748 shares during the period. Clear Creek Financial Management LLC bought a new position in Nutex Health in the second quarter worth about $397,000. Allianz Asset Management GmbH acquired a new position in Nutex Health in the second quarter valued at approximately $314,000. Finally, FNY Investment Advisers LLC bought a new position in shares of Nutex Health during the second quarter valued at approximately $414,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Price Performance

The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The company has a fifty day moving average price of $107.86 and a 200 day moving average price of $113.32. The company has a market capitalization of $665.65 million, a P/E ratio of 10.08 and a beta of -0.23.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.